The zebrafish (Danio rerio), a transparent in vivo model, offers rapid growth and strong genetic similarity to humans, allowing for real-time study of biological and pathological processes in the embryo and adult.

Microinjection of tumor cells into zebrafish embryos allows for real-time modeling of tumor progression and cell-microenvironment interactions, and for the development of innovative targeted therapies.

The Tg(fli1:EGFP) transgenic cell line enables the in vivo study of angiogenesis. It facilitates the analysis of the mechanisms involved in vascular diseases and cancer, as well as the screening of molecules and the analysis of new treatments targeting vascularization.

Zebrafish larvae are widely used for screening molecules, allowing in vivo evaluation of the therapeutic efficacy and toxicity of compounds on embryos and adults, while facilitating the development of new molecules targeting various pathologies.

Creation of transgenic lines of interest using technologies such as morpholinos or CRISPR/Cas9 by micro-injecting 1 cell into the zebrafish embryo.

Tissue regeneration tests in zebrafish allow the study of cellular and molecular mechanisms of tissue reconstruction and the identification of potential therapeutic strategies.

Personalized support for the scientific project at each experimental stage, from design to analysis.

The Xenofish platform ensures precise monitoring of results thanks to high-resolution imaging. The data allows for real-time observation of the effects of treatments and the evolution of pathologies.